Table of Contents PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: INTRODUCTION • Overview PART 05: MARKET LANDSCAPE • Overview • Market size and forecast • Five forces analysis PART 06: SEGMENTATION BY PRODUCT TYPE • Overview • Culture • Mantoux tuberculin test • Molecular testing • Smear microscopy • LF-LAM for PLHIV • Drug susceptibility testing PART 07: SEGMENTATION BY END-USER • Overview • Hospitals • Diagnostic laboratories PART 08: SEGMENTATION BY GEOGRAPHY • Overview • Regional comparison • APAC • Americas • EMEA • Key leading countries • Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS • Focus on partnerships and acquisitions for product development • Continuous technological advances • Expansion of healthcare infrastructure PART 12: VENDOR LANDSCAPE • Competitive landscape PART 13: KEY VENDOR ANALYSIS • Abbott • BD • bioMérieux • F. Hoffmann-La Roche • Thermo Fisher Scientific • Other prominent vendors PART 14: APPENDIX • List of abbreviations List of Exhibits Exhibit 01: Share of global TB diagnostics market of global IVD market 2016 (%) Exhibit 02: Global TB diagnostics market 2016-2021 ($ billions) Exhibit 03: Five forces analysis Exhibit 04: Global TB diagnostics market: Segmentation by product type 2016 (% share) Exhibit 05: Global TB diagnostics market: Segmentation by end-user 2016 (% share) Exhibit 06: Global TB diagnostics market by hospitals 2016-2021 ($ billions) Exhibit 07: Global TB diagnostics market by hospitals: Year-over-year growth 2017-2021 (%) Exhibit 08: Global TB diagnostic market by diagnostic laboratories 2016-2021 ($ billions) Exhibit 09: Global TB diagnostics market by diagnostic laboratories: Year-over-year growth 2017-2021 (%) Exhibit 10: Global TB diagnostics market: Segmentation by geography 2016-2021 (% share) Exhibit 11: Global TB diagnostics market: Regional comparison Exhibit 12: TB diagnostics market in APAC: Overview Exhibit 13: TB diagnostics market in APAC 2016-2021 ($ billions) Exhibit 14: TB diagnostics market in APAC: Year-over-year growth 2017-2021 (%) Exhibit 15: TB diagnostics market in Americas: Overview Exhibit 16: TB diagnostics market in Americas 2016-2021 ($ billions) Exhibit 17: TB diagnostics market in Americas: Year-over-year growth 2017-2021 (%) Exhibit 18: TB diagnostics market in EMEA: Overview Exhibit 19: TB diagnostics market in EMEA 2016-2021 ($ billions) Exhibit 20: TB diagnostics market in EMEA: Year-over-year growth 2017-2021 (%) Exhibit 21: Global TB diagnostics market: Key leading countries Exhibit 22: Global TB diagnostics market: Competitive structure analysis 2016 Exhibit 23: Abbott: Key highlights Exhibit 24: Abbott: Strength assessment Exhibit 25: Abbott: Strategy assessment Exhibit 26: Abbott: Opportunity assessment Exhibit 27: BD: Key highlights Exhibit 28: BD: Strength assessment Exhibit 29: BD: Strategy assessment Exhibit 30: BD: Opportunity assessment Exhibit 31: bioMérieux: Key highlights Exhibit 32: bioMérieux: Strength assessment Exhibit 33: bioMérieux: Strategy assessment Exhibit 34: bioMérieux: Opportunity assessment Exhibit 35: F. Hoffmann-La Roche: Key highlights Exhibit 36: F. Hoffmann-La Roche: Strength assessment Exhibit 37: F. Hoffmann-La Roche: Strategy assessment Exhibit 38: F. Hoffmann-La Roche: Opportunity assessment Exhibit 39: Thermo Fisher Scientific: Key highlights Exhibit 40: Thermo Fisher Scientific: Strength assessment Exhibit 41: Thermo Fisher Scientific: Strategy assessment Exhibit 42: Thermo Fisher Scientific: Opportunity assessment

Abbott, BD, bioMérieux, F. Hoffmann-La Roche, Thermo Fisher Scientific, Akonni Biosystems, Ameritek USA, Autobio Diagnostics, Cepheid, EIKEN CHEMICAL, GeTein BioMedical, Hain Lifescience, Hologic, NanoEnTek, Ortho Clinical Diagnostics, QIAGEN, and Siemens Healthineers.